All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial von Tubiana-Mathieu, N, Bougnoux, P, Becquart, D, Chan, A, Conte, P-F, Majois, F, Espie, M, Morand, M, Vaissiere, N, Villanova, G

Volltext

232 Final Results of a Phase II Study of the Combination of Oral Vinorelbine (NVBo), Capecitabine (X) and Trastuzumab (H) in HER2-positive Metastatic Breast Cancer (MBC) von Petruzelka, L, Ganju, V, Conte, P.F, Tubiana-Mathieu, N, Majois, F, Espie, M, Llombart, A, Gil, M. Gil, Villanova, G, Chan, A

Volltext

Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer von Agnelli, Giancarlo, George, Daniel J, Kakkar, Ajay K, Fisher, William, Lassen, Michael R, Mismetti, Patrick, Mouret, Patrick, Chaudhari, Umesh, Lawson, Francesca, Turpie, Alexander G.G

Volltext

Palmar fasciitis and arthritis: association with endometrial adenocarcinoma von Docquier, Ch, Majois, F, Mitine, C

Volltext

9305 Activity of sunitinib in advanced malignant melanoma and its correlation with potential predictive biomarkers von Decoster, L, Broek, I. Vande, Declerq, D, Anckaert, E, Majois, F, Baurain, J.F, Denys, H, DeMey, J, Neyns, B, DeGrève, J

Volltext

Biomarker analysis in a phase II study of sunitinib in patients with advanced melanoma von Decoster, L, Vande Broek, I, Neyns, B, Majois, F, Baurain, JF, Rottey, Sylvie, Rorive, A, Anckaert, E, De Mey, J, De Brakeleer, S, De Grève, J

Volltext

Adjuvant high-dose medroxyprogesterone acetate for early breast cancer: 13 years update in a multicentre randomized trial von Focan, C, Beauduin, M, Salamon, E, Greve, J de, Wasch, G de, Lobelle, J P, Majois, F, Tagnon, A, Tytgat, J, Belle, S van, Vandervellen, R, Vindevoghel, A

Volltext

All-oral vinorelbine (NVBo) and capecitabine (X) combination for chemotherapy-naive HER2-negative metastatic breast cancer (MBC) patients: efficacy and safety in an international p... von Tubiana-Mathieu, N, Bougnoux, P, Becquart, D, Chan, A, Majois, F, Espie, M, Palumbo, R, Llombart, A, Villanova, G, Conte, P.F

Volltext

2130 POSTER Updated analysis of an international phase II study evaluating an all-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative... von Tubiana-Mathieu, N, Bougnoux, P, Becquart, D, Chan, A, Majois, F, Espie, M, Perrot, O, Villanova, G, Conte, P.F

Volltext

Coronary artery spasm induced by 5-fluorouracil von LUWAERT, R. J, DESCAMPS, O, MAJOIS, F, CHAUDRON, J. M, BEAUDUIN, M

Volltext

Activity of sunitinib in advanced malignant melanoma and its correlation with potential predictive biomarkers von Decoster, L., Neyns, B., Vande Broek, I., Anckaert, E., De Clerck, D., De Mey, J., Majois, F., Baurain, J., Denys, H., De Greve, J.

Volltext

All-oral combination of oral vinorelbine (NVBo) and capecitabine (X) in HER2-negative metastatic breast cancer (MBC): latest results of a multicenter, international phase II trial... von Tubiana-Mathieu, N, Bougnoux, P, Becquart, D, Chan, A, Majois, F, Espie, M, Morand, M, Vaissiere, N, Villanova, G, Conte, P

Volltext

An international phase II study of an all-oral combination of oral vinorelbine (NVBo) and capecitabine (X) in HER2-negative metastatic breast cancer (MBC) von Tubiana-Mathieu, N., Bougnoux, P., Becquart, D., Chan, A., Majois, F., Espie, M., Aubert, D., Villanova, G., Conte, P. F.

Volltext

A phase I-II trial of induction chemotherapy with carboplatin and fluorouracil in locally advanced head and neck squamous cell carcinoma: a report from the UCL-Oncology Group, Belg... von GREGOIRE, V, BEAUDUIN, M, SYMANN, M, HUMBLET, Y, HAMOIR, M, LONGUEVILLE, J, MAJOIS, F, REMACLE, M, ROUSSEAU, F, SALAMON, E, WAMBERSIE, A

Volltext

Evaluation of vinorelbine (N) and trastuzumab (H) as first-line therapy for patients (pts) with HER2- positive metastatic breast cancer (HER2+ MBC): Impact on clinical response and... von Guillem Porta, V., Martin, M., Gil Gil, M., Kellokumpu-Lehtinen, P., Majois, F., Gasmi, J., Aubert, D., Bourrillon, O.

Volltext

Evaluation of vinorelbine (N) and trastuzumab (H) as first-line therapy for patients (pts) with HER2- positive metastatic breast cancer (HER2+ MBC): Impact on clinical response and... von Guillem Porta, V., Martin, M., Gil Gil, M., Kellokumpu-Lehtinen, P., Majois, F., Gasmi, J., Aubert, D., Bourrillon, O.

Volltext

Experience of the belgian society of medical oncology with single-administration 5 g/m2 ifosfamide with mesna as second- or third-line therapy in advanced breast cancer von PARIDAENS, R, FOCAN, C, T'HOOFT-ANDRY, M, MICHEL, J, PICCART, M, SALAMON, E, BEAUDIUN, M, CLOSON, M. T, TUENI, E, VINDEVOGHEL, A, MAJOIS, F

Volltext

Adjuvant Treatment with High Dose Medroxyprogesterone Acetate in Node-Negative Early Breast Cancer A 3-year Interim Report on a Randomized Trial (I) von Focan, C., Baudoux, A., Beauduin, M., Bunescu, U., Dehasque, N., Dewasch, L., Lobelle, J. P., Longeval, E., Majois, F., Mazy, V., Nickers, P., Salamon, E., Tagnon, A., Tytgat, J., van Belle, S., Vanderlinden, B., Vandervellen, R., Vindevoghel, A.

Volltext

Predictive value of activated tyrosine kinase (Tyr1248) in patients with HER2-overexpressing metastatic breast cancer (MBC) treated with trastuzumab + chemotherapy regimens von Giuliani, R, Paesmans, M, Durbecq, V, Di Leo, A, Larsimont, D, Cocquyt, V, Majois, F, Sotiriou, C, Piccart, M.J, Cardoso, F

Volltext

P102 Adjuvant high-dose medroxyprogesterone acetate (HD-MPA) for early breast cancer. 13 years update of a multicenter randomized trial von Focan, C., Beauduin, M., Salamon, E., de Greve, J., de Wasch, G., Lobelle, J.P., Majois, F., Tagnon, A., Tytgat, J., Van Belle, S., Vandervellen, R., Vindevoghel, A.

Volltext